Fabrication and Characterization of Drug-Loaded Conductive Poly(glycerol sebacate)/Nanoparticle-Based Composite Patch for Myocardial Infarction Applications

dc.contributor.authorZanjanizadeh Ezazi N.
dc.contributor.authorAjdary R.
dc.contributor.authorCorreia A.
dc.contributor.authorMäkilä E.
dc.contributor.authorSalonen J.
dc.contributor.authorKemell M.
dc.contributor.authorHirvonen J.
dc.contributor.authorRojas O.J.
dc.contributor.authorRuskoaho H.J.
dc.contributor.authorSantos H.A.
dc.contributor.organizationfi=teollisuusfysiikan laboratorio|en=Laboratory of Industrial Physics|
dc.contributor.organization-code1.2.246.10.2458963.20.66904373678
dc.converis.publication-id46299167
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/46299167
dc.date.accessioned2022-10-28T14:30:38Z
dc.date.available2022-10-28T14:30:38Z
dc.description.abstract<p>Heart tissue engineering is critical in the treatment of myocardial infarction, which may benefit from drug-releasing smart materials. In this study, we load a small molecule (3i-1000) in new biodegradable and conductive patches for application in infarcted myocardium. The composite patches consist of a biocompatible elastomer, poly(glycerol sebacate) (PGS), coupled with collagen type I, used to promote cell attachment. In addition, polypyrrole is incorporated because of its electrical conductivity and to induce cell signaling. Results from the in vitro experiments indicate a high density of cardiac myoblast cells attached on the patches, which stay viable for at least 1 month. The degradation of the patches does not show any cytotoxic effect, while 3i-1000 delivery induces cell proliferation. Conductive patches show high blood wettability and drug release, correlating with the rate of degradation of the PGS matrix. Together with the electrical conductivity and elongation characteristics, the developed biomaterial fits the mechanical, conductive, and biological demands required for cardiac treatment.</p>
dc.format.pagerange6899
dc.format.pagerange6909
dc.identifier.eissn1944-8252
dc.identifier.jour-issn1944-8244
dc.identifier.olddbid188692
dc.identifier.oldhandle10024/171786
dc.identifier.urihttps://www.utupub.fi/handle/11111/55209
dc.identifier.urnURN:NBN:fi-fe2021042826879
dc.language.isoen
dc.okm.affiliatedauthorMäkilä, Ermei
dc.okm.affiliatedauthorSalonen, Jarno
dc.okm.discipline114 Physical sciencesen_GB
dc.okm.discipline114 Fysiikkafi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherAmerican Chemical Society
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.doi10.1021/acsami.9b21066
dc.relation.ispartofjournalACS Applied Materials and Interfaces
dc.relation.issue6
dc.relation.volume12
dc.source.identifierhttps://www.utupub.fi/handle/10024/171786
dc.titleFabrication and Characterization of Drug-Loaded Conductive Poly(glycerol sebacate)/Nanoparticle-Based Composite Patch for Myocardial Infarction Applications
dc.year.issued2020

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
acsami.9b21066.pdf
Size:
7.44 MB
Format:
Adobe Portable Document Format
Description:
Publisher's PDF